Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17688654 | 0.94 | ALDH1A1 (0.48) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL907263 | 0.94 | CA12 (0.55) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL21151897 | 0.94 | ALDH1A1 (0.45) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL13333146 | 0.94 | MAPT (0.50) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL23280908 | 0.92 | ALDH1A1 (0.44) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL907548 | 0.92 | ALDH1A1 (0.51) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL907404 | 0.92 | ALDH1A1 (0.47) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL21151875 | 0.92 | ALDH1A1 (0.47) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL17402095 | 0.92 | KMT2A (0.46) | ALDH1A1MAPTRECQLHSD11B1KMT2A | |
| SCHEMBL17664887 | 0.91 | BCHE (0.46) | ALDH1A1MAPTRECQLHSD11B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282434-A2 | ANTIBODIES, USES THEREOF AND CONJUGATES THEREOF | Abzena (UK) Limited (GB) | 2023-11-29 | — | — | EP | disclosed |
| US-20230114866-A1 | VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES | SYNAFFIX B.V. (NL) | 2023-04-13 | — | — | US | disclosed |
| WO-2011077067-A1 | POLYMER CONJUGATES OF NON-GLYCOSYLATED ERYTHROPOIETIN | POLYTHERICS LIMITED (GB) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230114866-A1 | VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES | FUT5, FUCA1, FUT6 | ALDH1A1 928/4885MAPT 2954/4885RECQL 4535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.